Healthcare Holding B.V. Gilde Sells 20,516 Shares of Shoulder Innovations (NYSE:SI) Stock

Key Points

• Healthcare Holding B.V. Gilde sold 20,516 Shoulder Innovations shares at an average price of $22.61, generating $463,866.76. After the transaction, it retained 2.19 million shares worth approximately $49.5 million; the sale reduced its ownership by 0.93%.
• Shoulder Innovations shares recently traded at $22.24, near their 52-week high of $24.59, with a market capitalization of about $463 million. The company reported quarterly revenue of $17.18 million but missed earnings estimates, posting a loss of $0.49 per share.
• Analyst sentiment remains favorable, with six Buy ratings, one Hold and one Sell. Piper Sandler, BTIG Research and UBS each raised their price targets, while the consensus target stands at $23.50.

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 20,516 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $22.61, for a total transaction of $463,866.76. Following the completion of the sale, the insider directly owned 2,187,791 shares of the company's stock, valued at approximately $49,465,954.51. This trade represents a 0.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.62, for a total value of $15,404.22.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total transaction of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total transaction of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Performance

Shares of Shoulder Innovations stock traded up $0.18 on Monday, hitting $22.24. The stock had a trading volume of 75,051 shares, compared to its average volume of 128,345. The company's 50 day moving average price is $21.03 and its 200 day moving average price is $16.60. The stock has a market cap of $463.02 million and a price-to-earnings ratio of -11.58. Shoulder Innovations, Inc. has a 52-week low of $10.92 and a 52-week high of $24.59. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12.

Shoulder Innovations (NYSE:SI - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.46) by ($0.03). The business had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. On average, research analysts anticipate that Shoulder Innovations, Inc. will post -1.9 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Weiss Ratings upgraded Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a report on Monday, August 3rd. Piper Sandler reissued an "overweight" rating and issued a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. BTIG Research boosted their price objective on shares of Shoulder Innovations from $24.00 to $26.00 and gave the company a "buy" rating in a research report on Friday, August 7th. Finally, UBS Group lifted their price target on Shoulder Innovations from $27.00 to $28.00 and gave the company a "buy" rating in a report on Monday, August 10th. Six research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Shoulder Innovations presently has an average rating of "Moderate Buy" and a consensus price target of $23.50.

Institutional Trading of Shoulder Innovations

Several large investors have recently made changes to their positions in the stock. California State Teachers Retirement System grew its stake in Shoulder Innovations by 412.4% in the 2nd quarter. California State Teachers Retirement System now owns 2,941 shares of the company's stock valued at $60,000 after buying an additional 2,367 shares during the last quarter. Compass Financial Management LLC bought a new stake in shares of Shoulder Innovations in the 2nd quarter worth about $30,000. Bank of America Corp DE lifted its position in Shoulder Innovations by 43.7% during the 1st quarter. Bank of America Corp DE now owns 26,983 shares of the company's stock worth $392,000 after buying an additional 8,205 shares in the last quarter. Royal Bank of Canada raised its position in Shoulder Innovations by 7,046.3% in the 1st quarter. Royal Bank of Canada now owns 53,883 shares of the company's stock worth $783,000 after purchasing an additional 53,129 shares during the last quarter. Finally, KCM Capital Inc acquired a new position in Shoulder Innovations in the first quarter valued at approximately $509,000.

Shoulder Innovations Company Profile

Shoulder Innovations NYSE: SI is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source